Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

Go back to Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress
(NASDAQ: AUTL) Delayed: 1.56 --0 (-0%)
Previous Close $1.56    52 Week High
Open $1.56    52 Week Low
Day High $1.56    P/E N/A 
Day Low $1.56    EPS
Volume 23,097